Semaglutide × Peptira — Lab Test, January 2026
This lab doesn't publish a public lookup, so we can't confirm the certificate against the lab's own record. The document was reviewed before publication, but it rests on our review alone.
What portal verification means →Test results
This is a purity and identity analysis. Sterility, endotoxins, and heavy metals were not screened — a high purity figure says nothing about those.
About this test
Independent HPLC purity analysis of Semaglutide from Peptira on January 11, 2026. Reported purity: 99.86%. Net content: 11.15 mg against 10 mg labeled (112% of label). Tested content exceeds the labeled amount by 12%. Endotoxins: < 0.05 EU/mL (PASS for both replicates). Batch SEMA10-005. Sample source: shop-provided. Certificate of analysis attached.
Certificate of analysis
Have you tested this peptide?
Submit your third-party lab test to help the community verify purity claims. Every report is reviewed before publication.
Community discussion